Day: 2 August 2024

Inflation Takes a Breather, But Don’t Get Too Comfortable

When I say inflation takes a breather, I mean it’s not increasing as rapidly—not that it’s decreasing. Surely, you didn’t think inflation was actually going down, did you? Unsurprisingly, the conversations around inflation and the global economy have followed the trajectory predicted by economists. Inflation has lingered like a stubborn piece of chewy nougat caramel, […]

Goldman Sachs, Moelis & Co: Advisory on Arctos’ €1.3bn Acquisition of Hayfin from BCI

Goldman Sachs and Moelis & Company have played pivotal roles as financial advisors in the management buyout of Hayfin Capital Management, facilitated by Arctos Partners. In this strategic move, Arctos will acquire the majority stake previously held by British Columbia Investment Management Corporation (BCI) in Hayfin. The financial details of the

Brookfield Asset Management: Acquisition of the Thermal Management Business of nVent for $1.7bn

Brookfield Asset Management has struck a deal to acquire nVent Electric plc’s Thermal Management business for $1.7 billion in cash. This significant transaction includes the well-known RAYCHEM and TRACER brands, signaling a strategic shift for nVent towards a more streamlined focus on electrical connection and protection solutions. The sale, expected to close

UBS Exclusive: Iqbal Khan Takes on New Dual Role Including Co-Head of Global Wealth Management

UBS has announced a strategic move, positioning Iqbal Khan in Hong Kong to spearhead its Asian operations and co-lead its global wealth management. Khan’s relocation is pivotal, highlighting Asia’s critical role in UBS’s expansion strategy, especially in wealth management. He will divide his time

Centerview Partners Exclusive: Advisory on Otsuka Pharmaceutical’s $1.1bn Acquisition of Jnana Therapeutics

Centerview Partners played a pivotal role as the exclusive financial advisor in Otsuka Pharmaceutical’s strategic acquisition of Jnana Therapeutics Inc., a deal valued at up to $1.125 billion. Otsuka, a global leader in healthcare, will enhance its portfolio in specialty and autoimmune diseases through this acquisition. The agreement stipulates an upfront